Clinical, biochemical profile and atherosclerotic cardiovascular risk score (ASCVD) in patients with high HDL cholesterol

被引:0
|
作者
Mallya, Raksha Udupi [1 ]
Vidyasagar, Sudha [1 ]
Varashree, B. S. [2 ]
Sukumar, Cynthia Amrutha [1 ]
机构
[1] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Gen Med, Manipal 576104, Karnataka, India
[2] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India
关键词
ASCVD; CETP; HDL cholesterol; Lipidology; METs; CORONARY-HEART-DISEASE; ALCOHOL-CONSUMPTION; ATHEROGENIC DYSLIPIDEMIA; HYPERTENSION; POPULATION; JAPANESE; GENE;
D O I
10.1007/s11845-025-03878-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIt was observed that many people in the western coastal belt were found to have a high HDL cholesterol, the cause of which was not known. This study was done to learn about the factors contributing to the high HDL cholesterol in these patients and its effect on ASCVD risk.MethodsIn this prospective, case control study, 150 patients were recruited, of which 63 were cases (patients with high HDL cholesterol), and 87 were controls (patients with normal HDL cholesterol). Details regarding their diet, sea-food consumption, habits, comorbidities, daily activity (using GPAQ questionnaire), and blood reports were collected. ASCVD risk score was calculated using an online ASCVD risk estimator. Blood samples of 96 patients (cases 40, controls 56) was tested for cholesterol esterase transfer protein (CETP) levels using ELISA, and the results were compared.ResultsPatients with high HDL cholesterol were found to be physically more active and had median metabolic equivalent (METs) of 4680 (1200, 8580) compared with controls with median METs of 1680 (720, 5580), P-0.013. Cases had a lower mean BMI 23.09(SD-3.69), than in patients with normal HDL cholesterol with a mean of 24.41(SD-4.01), P-0.04. Cases also had a lower triglyceride level (91(69,118) in cases vs 121 (80,151) in controls, P-0.002. Alcohol and sea food consumption had no role on HDL levels in this study. The median CETP level was lower in patients with high HDL levels, 0.336(0.08, 0.336) versus 1.435(0.061, 2.893) in the control group although not statistically significant. Patients with high HDL cholesterol were found to have a significantly lower median 10-year ASCVD risk score 3.05 (0.6, 8.95), compared with patients with normal HDL 6.45 (2.7,14.2).ConclusionPatients with high HDL cholesterol were found to be physically more active, had a lower BMI, a lower triglyceride level, and a lower ASCVD risk compared with controls. They also had a lower CETP level. Further research will be required to determine the normal CETP level in Indian population, their genetic makeup, and whether it has a role in cardiovascular protection.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Determination of cardiovascular risk in adult patients with haemophilia using the Framingham risk score and the atherosclerotic cardiovascular disease score
    Conde, Aidee
    Ramirez Gomez, Mariana
    Varela Tapia, Clara Lilia
    HAEMOPHILIA, 2024, 30 : 127 - 127
  • [32] A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE
    Descamps, Olivier S.
    Cooney, Marie Therese
    De Backer, Guy
    Graham, Ian
    ATHEROSCLEROSIS, 2012, 222 (02) : 564 - 566
  • [33] Physicians' Perspectives on Race and Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator
    Okah, Ebiere
    Adeniran, Oluwamuyiwa
    Mihas, Paul
    Sloane, Philip
    ANNALS OF FAMILY MEDICINE, 2024, 22
  • [34] Physicians' Perspectives on the Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator.
    Okah, Ebiere
    Adeniran, Oluwamuyiwa
    Mihas, Paul
    Sloane, Philip
    ANNALS OF FAMILY MEDICINE, 2024, 22
  • [35] HDL: Fact, fiction, or function? HDL cholesterol and cardiovascular risk
    Allard-Ratick, Marc P.
    Kindya, Bryan R.
    Khambhati, Jay
    Engels, Marc C.
    Sandesara, Pratik B.
    Rosenson, Robert S.
    Sperling, Laurence S.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (02) : 166 - 173
  • [36] Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment
    Delialis, Dimitrios
    Georgiopoulos, Georgios
    Aivaliot, Evmorfia
    Mavraganis, Georgios
    Dimopoulou, Angeliki-Maria
    Sianis, Alexandros
    Aggelidakis, Lasthenis
    Patras, Raphael
    Petropoulos, Ioannis
    Ioannou, Sofia
    Syrigou, Rodanthi
    Chazidou, Sofia
    Kanakakis, Ioannis
    Stellos, Konstantinos
    Stamatelopoulos, Kimon
    HELLENIC JOURNAL OF CARDIOLOGY, 2022, 66 : 26 - 31
  • [37] Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment
    Carr, Stuart S.
    Hooper, Amanda J.
    Sullivan, David R.
    Burnett, John R.
    PATHOLOGY, 2019, 51 (02) : 148 - 154
  • [38] HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients
    Kopecky, Chantal
    Ebtehaj, Sanam
    Genser, Bernd
    Drechsler, Christiane
    Krane, Vera
    Antlanger, Marlies
    Kovarik, Johannes J.
    Kaltenecker, Christopher C.
    Parvizi, Mojtaba
    Wanner, Christoph
    Weichhart, Thomas
    Saeemann, Marcus D.
    Tietge, Uwe J. F.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (03): : 769 - 775
  • [39] HDL CHOLESTEROL EFFLUX IS NOT PREDICTIVE OF CARDIOVASCULAR RISK IN DIABETIC PATIENTS ON HEMODIALYSIS
    Kopecky, Chantal
    Ebtehaj, Sanam
    Genser, Bernd
    Wanner, Christoph
    Saeemann, Marcus D.
    Tietge, Uwe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 253 - 253
  • [40] HDL CHOLESTEROL AS CARDIOVASCULAR RISK FACTOR IN UREMIA
    DELAVELLE, F
    TROMBERT, JC
    CANARELLI, G
    KIDNEY INTERNATIONAL, 1979, 16 (01) : 94 - 94